Cancer BiologybioRxivPreprint
BIRC5 dependency defines a targetable vulnerability in TP53 mutant acute myeloid leukemia
Ahmed M. Mamdouh, Fang Qi Lim, Yang Mi…·Shruti Bhatt
This study identifies BIRC5 as a targetable vulnerability in TP53 mutant AML, showing that survivin/IAP inhibitors can overcome therapy resistance.
2 citations